p16(CDKN2) gene polymorphism:: association with histologic subtypes of epithelial ovarian cancer in China

被引:18
作者
Yan, L. [1 ,2 ]
Na, W. [2 ]
Shan, K. [3 ]
Xiao-Wei, M. [3 ]
Wei, G. [2 ]
Shu-Cheng, C. [3 ]
机构
[1] Hebei Med Univ, Hosp 4, Hebei Canc Inst, Shijiazhuang 050011, Peoples R China
[2] Hebei Med Univ, Hosp 4, Dept Mol Biol, Shijiazhuang 050011, Peoples R China
[3] Hebei Med Univ, Hosp 4, Dept Obstet & Gynaecol, Shijiazhuang 050011, Peoples R China
基金
美国国家科学基金会;
关键词
epithelial ovarian cancer; haplotype; p16; single nucleotide polymorphism; susceptibility;
D O I
10.1111/j.1525-1438.2007.00953.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p16 is an important tumor suppressor gene, which is inactivated in many kinds of tumors. The common variants of p16 may be associated with the risk of certain tumors development. We analyzed the frequency of two adjacent polymorphisms in p16 exon 3 (540C -> G and 580C -> T) and their haplotype in blood samples from epithelial ovarian cancer (EOC) patients and healthy controls using polymerase chain reaction-restriction fragment length polymorphism. The results showed that the genotype frequency of p16 580C -> T polymorphism was significantly different among histologic subtypes of EOC (P = 0.02). T allele carriers significantly reduced the risk of serous EOC; the adjusted odds ratio was 0.40 (95% CI = 0.19-0.84). There are neither association between p16 540C -> G polymorphism and EOC development, progression, nor association between the haplotypes of two single nucleotide polymorphisms and the tumor development. Our results suggested that the p16 580C -> T polymorphism might affect the individual susceptibility to specific subtypes of EOC. Different types of ovarian cancer might adopt distinct carcinogenetic pathways. However, this result may be further validated in a larger sample of patients.
引用
收藏
页码:30 / 35
页数:6
相关论文
共 32 条
[1]  
Abbaszadegan MR, 2005, J GASTROINTEST CANC, V36, P47, DOI 10.1385/IJGC:36:1:047
[2]   CDKN2A variants in a population-based sample of queensland families with melanoma [J].
Aitken, J ;
Welch, J ;
Duffy, D ;
Milligan, A ;
Green, A ;
Martin, N ;
Hayward, N .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (05) :446-452
[3]  
Cao ZY, 2004, CHINESE OBSTET GYNEC, P2153
[4]   Inactivation of tumor suppressor genes p15INK4b and p16INK4a in primary cutaneous b cell lymphoma [J].
Child, FJ ;
Scarisbrick, JJ ;
Calonje, E ;
Orchard, G ;
Russell-Jones, R ;
Whittaker, SJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (06) :941-948
[5]   THE RETINOBLASTOMA PROTEIN AND THE REGULATION OF CELL CYCLING [J].
COBRINIK, D ;
DOWDY, SF ;
HINDS, PW ;
MITTNACHT, S ;
WEINBERG, RA .
TRENDS IN BIOCHEMICAL SCIENCES, 1992, 17 (08) :312-315
[6]   The 3′ untranslated region of messenger RNA:: A molecular 'hotspot' for pathology? [J].
Conne, B ;
Stutz, A ;
Vassalli, JD .
NATURE MEDICINE, 2000, 6 (06) :637-641
[7]  
Debniak T, 2005, CANCER RES, V65, P835
[8]  
Dong Y, 1997, INT J CANCER, V74, P57, DOI 10.1002/(SICI)1097-0215(19970220)74:1<57::AID-IJC10>3.0.CO
[9]  
2-F
[10]   Analysis of p16INK4A gene promoter in male germ-cell tumors: identification of a new point mutation [J].
Fombonne, J ;
Devouassoux-Shisheboran, M ;
Bouvier, R ;
Droz, JP ;
Benahmed, M ;
Krantic, S .
CANCER DETECTION AND PREVENTION, 2004, 29 (01) :1-7